BSECompany Update6d ago · 30 Jul 2026, 12:17 pm
Please find enclosed intimation of audio recordings of the conference call held today 30th July, 2026.
Piramal Pharma Ltd · 543635
✦ AI SummaryResults
Piramal Pharma Ltd has released the audio recording of a conference call held on 30th July, 2026, discussing the unaudited financial results for the quarter ended 30th June, 2026. The recording is available on the company's website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
e93324e9-e816-4887-b9ea-1d5fef4fce75.pdf
View document text
30th July, 2026
BSE Limited National Stock Exchange of India Limited
P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex,
Mumbai- 400 001 Bandra (East), Mumbai – 400 051
BSE scrip code: 543635 NSE symbol: PPLPHARMA
Sub: Audio Recording of Conference Call on the Unaudited Financial Results
(Standalone and Consolidated) for the quarter ended 30th June, 2026
Dear Sir / Madam,
In continuation of our letter dated 20th July, 2026 and pursuant to Regulation 30(6) of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of
the Conference Call held today i.e. on 30th July, 2026, on the Unaudited Financial Results
(Standalone and Consolidated) of the Company for the quarter ended 30th June, 2026, is
available on the Company’s website at https://www.piramalpharma.com/financial-reports.
Kindly take this on record.
Thank you.
Yours truly,
For Piramal Pharma Limited
Maneesh Sharma
Company Secretary & Compliance Officer
Piramal Pharma Limited
CIN: L24297MH2020PLC338592
Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India
Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com
www.piramalpharma.com